Considering 30-days investment horizon, SanofiAventis is expected to under-perform the Novartis. In addition to that, SanofiAventis is 2.16 times more volatile than Novartis AG. It trades about -0.31 of its total potential returns per unit of risk. Novartis AG is currently generating about -0.43 per unit of volatility. If you would invest 5,502 in Novartis AG on April 26, 2012 and sell it today you would lose (306.00) from holding Novartis AG or give up 5.56% of portfolio value over 30 days.
Diversification
Modest diversification
Overlapping area represents amount of risk that can be diversified away by holding SanofiAventis and Novartis AG in the same portfolio (assuming nothing else is changed)